AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 165 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $918,000 | -49.4% | 128,042 | 0.0% | 0.09% | -52.7% |
Q1 2019 | $1,814,000 | -19.1% | 128,042 | -22.7% | 0.18% | -22.9% |
Q4 2018 | $2,242,000 | +211.0% | 165,742 | +410.0% | 0.24% | +286.9% |
Q3 2018 | $721,000 | +50.5% | 32,500 | +11.3% | 0.06% | +69.4% |
Q2 2018 | $479,000 | – | 29,200 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $102,442,000 | 9.84% |
TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $77,176,000 | 1.36% |
Sivik Global Healthcare LLC | 600,000 | $2,856,000 | 0.95% |
THB ASSET MANAGEMENT | 651,150 | $3,099,000 | 0.90% |
Eversept Partners, LP | 886,587 | $4,220,154 | 0.58% |
Spark Investment Management LLC | 30,100 | $143,000 | 0.52% |
GLOBEFLEX CAPITAL L P | 240,680 | $1,146,000 | 0.29% |
Alambic Investment Management, L.P. | 19,493 | $93,000 | 0.23% |
GSA CAPITAL PARTNERS LLP | 49,901 | $238,000 | 0.13% |
C M BIDWELL & ASSOCIATES LTD | 29,550 | $141,000 | 0.13% |